GPTHEALTHGPT Healthcare Ltd.

₹147.44-1.04%

Market Cap

₹1,218.92 Cr

Stock P/E

29.23

ROCE

25.56%

ROE

33.06%

Book Value

₹0.00

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings

Distribution

Promoter

Institution

Public

Others

From Last Concall

POSITIVES

•
On the 2nd of May 2025, we commissioned a 158-bed facility at Pachpedi Naka in Raipur. This facility has been established in an asset-light model and it's fully operational.
•
Revenue from operations grew by 9.5% to INR107 crores for the quarter ended June FY26.

NEGATIVES

•
Raipur hospital shows initial EBITDA losses; approximately INR4.5 crores in Q1 FY26.
•
Dum Dum occupancies are at sub-60% versus 70% in the previous year.

Peers Summary

Sector Leader

GPT Healthcare Ltd. exhibits strong profitability metrics with a high ROE of 33.06% and a reasonable debt level, making it a solid player within its peer group. However, its growth metrics show a stagnation in revenue growth YoY, indicating potential challenges ahead. The sector has a mix of strong performers and some financially weak firms, suggesting a cautious approach for investors.

Key Points

• GPT Healthcare Ltd. shows high profitability with a ROE of 33.06%.
• Best value picks include Aster DM Healthcare Ltd. due to its low PE ratio and decent margins.
• Financially weak companies include Fortis Healthcare Ltd. with an extremely high PE ratio of 1094.63.

Top Performers

GPT Healthcare Ltd.

High ROE of 33.06% and low debt-to-equity ratio of 0.6039.

Apollo Hospitals Enterprise Ltd.

Good growth trajectory with a revenue growth of 14.73% YoY and reasonable PE ratio.

Global Health Ltd.

Solid ROA of 10.72% and a robust revenue growth of 21.56% YoY.

Explore

Watchlists